Visual Remapping to Aid Reading With Field Loss

March 8, 2024 updated by: University of Minnesota

Remapping the Visual Field to Aid Reading With Central Scotomas

Reading performance in patients with Central Vision Loss and age matched controls with artificial scotomas will be measured with and without different kinds of remapping of missing text to different parts of the visual field.

Study Overview

Detailed Description

Following initial characterization of their visual field loss, the participant's performance in reading tasks will be measured with and without remapping. Tasks will include reading groups of random letters, words, simple sentences, and "natural" text from the environment (taken from phone apps, signage, etc). Different kinds of remappings will be used by participants, including traditional and personalized remapping. For control observers, differently shaped artificial scotomas will be used.

Participants interested in the study will be brought in for an initial visit. All participants will be administered the MMSE. Observers who pass the criteria for the study will then have the remainder of the procedures described to them verbally prior to undergoing the remainder of the consent process (see below). Participants will then undergo a standard exam at the UMN eye clinic, if they have not had one within the last month.

Participants will then have their scotomas mapped using a microperimeter housed in the psychology department to give size and shape information. Additional perimetry may also be conducted using either of the two displays (either HMD or desk mounted computer monitor) we have developed. Here, patients will be asked to fixate at a spot on screen and identify visual stimuli presented at different regions of the screen. The size and locations of visual stimuli patients were unable to identify will provide the size and location of the scotoma. Another additional manual perimetry protocol may be conducted as well. This would involve asking subjects to fixate at the center of a tangent screen, and asking them to identify dots temporarily presented on the screen by the researcher using a laser pointer. The locations of dots that patients are unable to identify will provide the size and location of the scotoma. The location and extent of each eye's scotoma and PRL will be used as software inputs on either device. Perimetry using one or all of the methods above will be performed until acceptable information about the scotoma extent and location is obtained.

In a second visit, participants will perform the visual tasks that are used as the basis of their personalized remapping, letter perimetry. Participants will first view and report three randomly selected horizontally arranged letters placed at different locations in the visual field. This letter perimetry task will take about 40 min and will cover a large part of the visual field.

Participants will then read single words whose letters have been displaced from horizontal in various ways that comprise candidate remappings generated on the basis of the letter perimetry results. This personalization test will take about 40 minutes, and will find a good remapping strategy for the individual. Subjects will then be introduced to the reading tasks that comprise the remainder of the study

In 6 additional sessions, participants will perform various reading tasks using different remappings. In all of these, text will be displayed on the screen, and the task is simply to read aloud what was presented. Two sessions will involve reading single words, one session will involve reading strings of 3 letters that are not arranged horizontally, two sessions will involve reading short sentences, and one session will involve reading naturalistic text (from phone apps, signage, menus, etc). In all sessions, some reading will be with remapping, some will be without. Both traditional and personalized remapping will be used.

In all these sessions, the eye tracker will be calibrated to participants' individual head and eye position. This will involve fixating at different points on the device screen (HMD or desk-mounted) as the eye is imaged by the eye trackers. This may take up to 45 minutes in the initial session, if various combinations of head and eye positions are required for the eye trackers to work well. But once completed, calibration is much faster in subsequent sessions. Quick perimetry validation may also be conducted in each session.

Throughout all testing, patients will be asked if they feel any discomfort, and will be able to take a break or quit testing at any point.

Including the initial visit, testing for any given patient is anticipated to last no more than eight sessions over eight weeks. Enrolling participants, testing, and data analysis for all participants is anticipated to take five years from the date of enrollment of the first participant.

Study Type

Interventional

Enrollment (Estimated)

108

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Stephen Engel, Ph.D.
  • Phone Number: 612-625-5571
  • Email: engel@umn.edu

Study Contact Backup

Study Locations

    • Minnesota
      • Minneapolis, Minnesota, United States, 55455
        • Recruiting
        • University of Minnesota
        • Contact:
          • Stephen Engel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. 16 years or older
  2. Central vision loss of at least 5 deg diameter, including the fovea, from bilateral central scotomas
  3. Stable fixation (+/- 1 deg) using their PRL.
  4. No cognitive impairment as indicated by a Mini-Mental State Examination (MMSE).
  5. Satisfactory calibration achievable using eye tracker

Exclusion Criteria:

  1. Central vision loss of less than 5 deg diameter; scotomas that do not cover the fovea; unilateral scotomas
  2. Poor fixation (worse than+/- 1 deg) using their PRL.
  3. Cognitive impairment as indicated by a Mini-Mental State Examination (MMSE).
  4. Satisfactory calibration not achievable using eye tracker

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patients with scotoma
No remapping (control condition), traditional remapping, personalized remapping
Shifting text outside of scotoma
Shifting text based on individual letter-based perimetry
Active Comparator: Normally sighted with artificial scotoma
No remapping (control condition), traditional remapping, personalized remapping
Shifting text outside of scotoma
Shifting text based on individual letter-based perimetry

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reading Speed for Individual Words
Time Frame: Measured during third visit- each visit is one day only and this measure refers to data gathered during a < 1 hr long reading session during that day
How quickly participants can correctly read displayed text
Measured during third visit- each visit is one day only and this measure refers to data gathered during a < 1 hr long reading session during that day
Reading Speed for Sentences
Time Frame: Measured during fourth visit- each visit is one day only and this measure refers to data gathered during a < 1 hr long reading session during that day
How quickly participants can correctly read displayed text
Measured during fourth visit- each visit is one day only and this measure refers to data gathered during a < 1 hr long reading session during that day
Reading Speed for Natural Text Samples
Time Frame: Measured during fifth visit; each visit is one day only and this measure refers to data gathered during a < 1 hr long reading session during that day
How quickly participants can correctly read displayed text
Measured during fifth visit; each visit is one day only and this measure refers to data gathered during a < 1 hr long reading session during that day
Reading error rate for Individual Words
Time Frame: Measured during third visit; each visit is one day only and this measure refers to data gathered during a < 1 hr long reading session during that day
How many mistakes participants make
Measured during third visit; each visit is one day only and this measure refers to data gathered during a < 1 hr long reading session during that day
Reading error rate for Sentences
Time Frame: Measured during fourth visit; each visit is one day only and this measure refers to data gathered during a < 1 hr long reading session during that day
How many mistakes participants make
Measured during fourth visit; each visit is one day only and this measure refers to data gathered during a < 1 hr long reading session during that day
Reading error rate for Natural Text Samples
Time Frame: Measured during fifth visit; each visit is one day only and this measure refers to data gathered during a < 1 hr long reading session during that day
How many mistakes participants make
Measured during fifth visit; each visit is one day only and this measure refers to data gathered during a < 1 hr long reading session during that day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Eye fixation quality for words
Time Frame: Measured during third visit; each visit is one day only and this measure refers to data gathered during a < 1 hr long reading session during that day
Variance of x and y eye position coordinates computed during fixation periods while reading
Measured during third visit; each visit is one day only and this measure refers to data gathered during a < 1 hr long reading session during that day
Eye fixation quality for sentences
Time Frame: Measured during fourth visit; each visit is one day only and this measure refers to data gathered during a < 1 hr long reading session during that day
Variance of x and y eye position coordinates computed during fixation periods while reading
Measured during fourth visit; each visit is one day only and this measure refers to data gathered during a < 1 hr long reading session during that day
Eye movement quality for sentences
Time Frame: Measured during fourth visit
Number off leftward (regressive) eye movements during sentence reading
Measured during fourth visit
Eye fixation quality for natural text samples
Time Frame: Measured during fifth visit; each visit is one day only and this measure refers to data gathered during a < 1 hr long reading session during that day
Variance of x and y eye position coordinates computed during fixation periods while reading
Measured during fifth visit; each visit is one day only and this measure refers to data gathered during a < 1 hr long reading session during that day
Eye movement quality for natural text samples
Time Frame: Measured during fifth visit; each visit is one day only and this measure refers to data gathered during a < 1 hr long reading session during that day
Number off leftward (regressive) eye movements during natural text reading
Measured during fifth visit; each visit is one day only and this measure refers to data gathered during a < 1 hr long reading session during that day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stephen Engel, Ph.D., University of Minnesota

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2022

Primary Completion (Estimated)

November 30, 2024

Study Completion (Estimated)

November 30, 2024

Study Registration Dates

First Submitted

January 28, 2019

First Submitted That Met QC Criteria

February 18, 2019

First Posted (Actual)

February 21, 2019

Study Record Updates

Last Update Posted (Actual)

March 12, 2024

Last Update Submitted That Met QC Criteria

March 8, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • REMAP002

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Perimetry, psychophysical and eye-tracking data will be deidentified upon acquisition, and indexed using only a subject code. These data will be stored on a secure server for sharing upon request by a PI of a research team. We will offer psychophysical and eye tracking data along with appropriate metadata specifying details of the test (remapping used, stimulus protocol, etc) and data format.

IPD Sharing Time Frame

Once results are published.

IPD Sharing Access Criteria

Research group.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Age-related Macular Degeneration

Clinical Trials on Traditional Remapping

3
Subscribe